preloader

WYETH

F. NO. 8 (22)/99/DP/NPPA-Div.II
GOVERNMENT OF INDIA
MINISTRY OF CHEMICALS AND FERTILIZERS
NATIONAL PHARMACEUTICAL PRICING AUTHORITY

NEW DELHI, DATED THE 28/12/1999

ORDER

In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 and paragraph 11 of the Drugs (Price Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby fixes/revises the prices as specified in column (7) of the Table hereto annexed as the retail price/revised retail price, exclusive of local tax if any, in relation to each of the formulations specified in the corresponding entry in column (2) of the said Table with pack size specified in the corresponding entries in column (3) thereof:

Sl. No. Name of the formulation Pack Size Existing Retail Price Retail Price without Excise Duty (Rs.) ExciseDuty (Rs.) Revised Retail Price with Excise Duty (Rs.)
(1) (2) (3) (4) (5) (6) (7)
1. Wysolone Tab. 5mg
Each tab contains
Prednisolone – 5mg
10’s
GPBL
6.03 6.78 0.85 7.63
2. Wysolone Tab. 10mg
Each tab contains
Prednisolone – 10mg
10’s
GPST
11.62 13.10 1.62 14.72
3. Wysolone Tab. 20mg
Each tab contains
Prednisolone – 20mg
6’s
Al_St
13.65 15.48 1.92 17.40

2. This order shall be applicable if the manufacturer of the formulation specified in column (2) of the Table above has complied with the requirements, if any, of

a. the Drugs and Cosmetics Act, 1940 (23 of 1940) and the rules made thereunder; and

b. the Industries (Development and Regulation) Act, 1951 (65 of 1951) as amended from time to time.

3. These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.

4. The prices given in Column 7 of the above table will remain valid subject to the condition that the company captively consumes the bulk drug Prednisolone produced by them and the company is required to submit the return by 10th of January, April, July and October of its preceding quarter to the Govt./NPPA regarding in-house production and consumption as well as procurement from other sources including imports of bulk drug Prednisolone.

PN/31/99/F

M/s. WYETH LEDERLE LTD.
Nyloc House
254 D-2, Dr. Annie Besant Road,
P.O. Box No. 9109 Worli,
Mumbai-400025

(S. K. BHATT)
Dy. Director

Last Page Updated: 16-01-2019